Skip to content
value.today
Silence Therapeutics PLC logo

Silence Therapeutics PLC

XRP2.F
$189 Mlast known market cap, Jul 2023 — no current value
Compare
World rank
—
no current market cap
Revenue
$14 M
Dec-2021 ending year
value.today research
Net income
$-46 M
-328.6% margin
value.today research
Employees
88
As of December 31, 2025
value.today research

Silence Therapeutics PLC in brief

Silence Therapeutics PLC is a listed company in the Biotechnology industry, based in the UK. It was founded in 1994. Its last known market value was $189 M (July 2023); there is no current figure. In the year to Dec 2021 it had sales of $14 M and a net loss of $46 M. It employs about 88 people. Its shares trade under the symbol XRP2.F (Frankfurt).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Silence Therapeutics PLC

Silence Therapeutics (Nasdaq: SLN) is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Silence Therapeutics PLC timeline

2 events, 1994–2015
  1. 1994
  2. 🏁
    · approximate
    Founded
  3. 2015
  4. •
    Legal Entity Identifier issued
    LEI 213800SSURRJBX85SQ91 registered.

Events of Silence Therapeutics PLC from Wikidata and the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$189 M$379 M$568 M$757 M2020202120222023

World rank over time

▼ down 5,543 places since 2020
2020-01-01: #12791#12,79120202021-01-01: #10423#10,42320212022-01-07: #11427#11,42720222022-12-25: #12208#12,20820222023-07-30: #18334#18,3342023

Rank in UK: #381 (Jan 2020) · #495 (Jan 2021) · #538 (Jan 2022) · #439 (Dec 2022) · #708 (Jul 2023)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-328.6%
Operating margin
-650.6%
Return on equity
-511.1%
Liabilities / assets
90.3%
Revenue per employee
$159 K
Profit per employee
$-523 K

Annual results

Revenue
$14 M
Operating income
$-91 M
Net income
$-46 M

Dec-2021 ending year

Balance sheet

Total assets
$113 M
Total liabilities
$102 M
Total equity
$9 M

Dec-2021 ending year

Top 92 institutional investors in Silence Therapeutics PLC#

As of Sep 30, 2026
92 institutions held 48.3 M shares on Sep 30, 2026. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Silence Therapeutics PLC
#InstitutionShares heldChange (shares)ValueFiled
1FMR LLC4,710,812New$51 MNov 10, 2026
2Siren, L.L.C.2,887,867-423,571 (-12.79%)$32 MNov 12, 2026
3Citadel Advisors LLC2,825,601+1,495,976 (+112.51%)$31 MNov 16, 2026
4Redmile Group, LLC2,460,894+296,117 (+13.68%)$27 MNov 16, 2026
5Tetragon Partners GP Ltd2,436,051+1,671,795 (+218.75%)$27 MNov 16, 2026
6Soleus Capital Management, L.P.2,385,700+1,755,700 (+278.68%)$26 MNov 16, 2026
7Balyasny Asset Management L.P.2,254,235+1,643,255 (+268.95%)$25 MNov 16, 2026
8Squadron Capital Management LLC2,085,000New$23 MNov 16, 2026
9TCG Crossover Management, LLC1,819,035-1,214,525 (-40.04%)$20 MNov 16, 2026
10Morgan Stanley1,761,030+1,357,858 (+336.79%)$19 MNov 13, 2026
11Nextech Invest Ltd.1,693,140+740,740 (+77.78%)$19 MNov 16, 2026
12Millennium Management LLC1,453,540+544,261 (+59.86%)$16 MNov 16, 2026
13BNP Paribas Financial Markets1,173,108+1,014,158 (+638.04%)$13 MNov 12, 2026
14Nantahala Capital Management, LLC1,162,384-1,531,078 (-56.84%)$13 MNov 13, 2026
15Qube Research & Technologies Ltd1,058,988+895,043 (+545.94%)$12 MNov 13, 2026
16Ameriprise Financial Inc1,038,369+668,317 (+180.60%)$11 MNov 16, 2026
17Ikarian Capital, LLC821,790-8,994 (-1.08%)$9 MNov 16, 2026
18Susquehanna International Group, LLP820,638+636,119 (+344.74%)$9 MNov 16, 2026
19Persistent Asset Partners Ltd781,965+766,795 (+5054.68%)$9 MNov 13, 2026
20Montanova Capital, LLC740,740New$8 MNov 16, 2026
21RTW Investments, LP700,000New$8 MNov 16, 2026
22KVP Capital Advisors, LP684,123New$7 MNov 16, 2026
23Two Sigma Investments, LP679,702+558,698 (+461.72%)$7 MNov 16, 2026
24ADAR1 Capital Management, LLC629,654+291,281 (+86.08%)$7 MNov 16, 2026
25UBS Group AG609,678+366,526 (+150.74%)$7 MNov 10, 2026
Show all 92: investors 26 to 92
Institutional investors 26 to 92 in Silence Therapeutics PLC
#InstitutionShares heldChange (shares)ValueFiled
26Caption Management, LLC518,674+356,198 (+219.23%)$6 MNov 16, 2026
27Toronto Dominion Bank486,189New$5 MNov 16, 2026
285AM Venture Management, LLC476,2000 (0.00%)$5 MNov 16, 2026
29Goldman Sachs Group Inc462,831+306,902 (+196.82%)$5 MNov 16, 2026
30Affinity Asset Advisors, LLC450,000New$5 MNov 13, 2026
31Lombard Odier Asset Management (Europe) Ltd423,857New$5 MNov 16, 2026
32Acuta Capital Partners, LLC393,583New$4 MNov 16, 2026
33Alyeska Investment Group, L.P.364,920New$4 MNov 16, 2026
34Seven Fleet Capital Management LP350,000+289,893 (+482.29%)$4 MNov 16, 2026
35BlackRock, Inc.330,529+110,612 (+50.30%)$4 MNov 13, 2026
36Woodline Partners LP300,000New$3 MNov 16, 2026
37Fred Alger Management, LLC250,142+73,142 (+41.32%)$3 MNov 16, 2026
38Seven Grand Managers, LLC250,000New$3 MNov 16, 2026
39Fortress Investment Group LLC230,000New$3 MNov 16, 2026
40Cantor Fitzgerald, L. P.217,990New$2 MNov 16, 2026
41Sofinnova Investments, Inc.211,802New$2 MNov 16, 2026
42Aberdeen Group plc205,865New$2 MNov 10, 2026
43Bank Of Montreal /can/201,176-558 (-0.28%)$2 MNov 9, 2026
44Boothbay Fund Management, LLC200,568+2,221 (+1.12%)$2 MNov 16, 2026
45Nomura Holdings Inc199,546New$2 MNov 16, 2026
46Barclays PLC195,958+192,540 (+5633.12%)$2 MNov 6, 2026
47Jane Street Group, LLC192,595-176,556 (-47.83%)$2 MNov 12, 2026
48Ishara Investments LP160,000+104,650 (+189.07%)$2 MNov 16, 2026
49Renaissance Technologies LLC152,200+135,270 (+799.00%)$2 MNov 12, 2026
50Squarepoint Ops LLC147,577+31,659 (+27.31%)$2 MNov 9, 2026
51Diadema Partners LP135,000New$1 MNov 16, 2026
52Adage Capital Partners GP, L.L.C.130,000New$1 MNov 16, 2026
53Quadrature Capital Ltd101,242-16,887 (-14.30%)$1 MNov 13, 2026
54M28 Capital Management LP101,2030 (0.00%)$1 MNov 13, 2026
55Soros Fund Management LLC100,000New$1 MNov 13, 2026
56Burkehill Global Management, LP100,000New$1 MNov 16, 2026
57HSBC Holdings PLC76,201-46,633 (-37.96%)$1 MNov 16, 2026
58Marshall Wace, LLP60,322-11,717 (-16.26%)$1 MNov 13, 2026
59Tudor Investment Corp Et Al44,252New$0 MNov 16, 2026
60Royal Bank Of Canada41,962+41,936 (+161292.31%)$0 MNov 16, 2026
61Point72 Asset Management, L.P.40,192New$0 MNov 16, 2026
62Y-Intercept (Hong Kong) Ltd40,107New$0 MOct 16, 2026
63XTX Topco Ltd32,825-74,754 (-69.49%)$0 MNov 16, 2026
64Birchview Capital, LP30,000-41,218 (-57.88%)$0 MNov 13, 2026
65Bank Of America Corp /de/29,818+4,538 (+17.95%)$0 MNov 16, 2026
66State Street Corp21,800New$0 MNov 12, 2026
67Virtu Financial LLC18,022-7,619 (-29.71%)$0 MNov 17, 2026
68Geode Capital Management, LLC15,979-13,559 (-45.90%)$0 MNov 6, 2026
69Citigroup Inc15,027+1,810 (+13.69%)$0 MNov 4, 2026
70Graham Capital Management, L.P.14,258New$0 MNov 16, 2026
71Rhumbline Advisers12,088-1,727 (-12.50%)$0 MNov 10, 2026
72GAMMA Investing LLC11,207+144 (+1.30%)$0 MOct 8, 2026
73Wells Fargo & Company/mn9,100New$0 MNov 16, 2026
74China Universal Asset Management Co., Ltd.8,572+1,097 (+14.68%)$0 MOct 28, 2026
75PNC Financial Services Group, Inc.4,761New$0 MNov 6, 2026
76National Bank Of Canada /fi/4,001New$0 MNov 16, 2026
77FNY Investment Advisers, LLC4,000New$0 MOct 16, 2026
78Jpmorgan Chase & Co3,649-214 (-5.54%)$0 MNov 12, 2026
79Tower Research Capital LLC (TRC)3,060+1,421 (+86.70%)$0 MNov 16, 2026
80Jones Financial Companies Lllp2,5000 (0.00%)$0 MNov 13, 2026
81Mirae Asset Global Investments Co., Ltd.2,401+300 (+14.28%)$0 MOct 29, 2026
82Parallel Advisors, LLC1,906+606 (+46.62%)$0 MNov 3, 2026
83GF Fund Management Co. LTD.1,061+86 (+8.82%)$0 MOct 26, 2026
84Rialto Wealth Management, LLC1,0210 (0.00%)$0 MNov 16, 2026
85Caitong International Asset Management Co., Ltd843+802 (+1956.10%)$0 MOct 29, 2026
86Steward Partners Investment Advisory, LLC144+44 (+44.00%)$0 MNov 13, 2026
87Assetmark, Inc118New$0 MOct 21, 2026
88Nuveen, LLC114New$0 MNov 10, 2026
89Osaic Holdings, Inc.100New$0 MNov 12, 2026
90SBI Securities Co., Ltd.48+20 (+71.43%)$0 MOct 22, 2026
91Rockefeller Capital Management L.P.450 (0.00%)$0 MNov 13, 2026
92Nisa Investment Advisors, LLC18New$0 MOct 20, 2026

Superinvestors holding Silence Therapeutics PLC

1 of the well-known investors value.today follows, from their newest Form 13F.

Mutual funds holding Silence Therapeutics PLC#

9 funds hold shares worth $9 M. Since their previous reports 5 added shares and 0 sold, buying $6 M net.
Mutual funds holding Silence Therapeutics PLC
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Fidelity Advisor Biotechnology FundFidelity Management & Research Company LLC482,088$5 M—0.23%newJul 31, 2026
🇺🇸 iShares Biotechnology ETFBlackRock Fund Advisors185,777$2 M—0.02%+7.2%Jun 30, 2026
🇺🇸 Alger Small Cap Growth FundFred Alger Management, LLC105,679$1 M—0.54%newJul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC29,538$0 M—<0.01%no changeMay 31, 2026
🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc.9,532$0 M—0.01%+1.0%Jun 30, 2026
🇺🇸 Steward Values Enhanced International FundCrossmark Global Investments5,800$0 M—0.02%no changeJul 31, 2026
🇺🇸 ActivePassive International Equity ETFTrust for Professional Managers8,695$0 M—<0.01%newMay 31, 2026
🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC1,000$0 M—<0.01%no changeJun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC24$0 M—<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 9 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

How Silence Therapeutics PLC compares in Biotechnology

  • Revenue$14 M · higher than 47% of 647
  • Net margin-328.6% · higher than 18% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Silence Therapeutics PLC🇬🇧$189 M—-328.6%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jul 30, 2023 (last known)
Annual results:
Dec-2021 ending year
Balance sheet:
Dec-2021 ending year
Employees:
As of December 31, 2025
Profile updated:
Nov 15, 2026

Figures from value.today research, Wikipedia, Wikidata, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Silence Therapeutics PLC? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Silence Therapeutics PLC's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Silence Therapeutics PLC? Suggest a correction